JP Morgan Chase
UTHR icon

JP Morgan Chase’s United Therapeutics UTHR Stock Holding History

JP Morgan Chase’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$47.4M Buy
80,500
+80,100
+20,025% +$39.9M ﹤0.01% 1435
2025
Q4 		$195K Sell
400
-4,500
-92% -$2.1M ﹤0.01% 5559
2025
Q3 		$2.05M Sell
4,900
-8,100
-62% -$2.72M ﹤0.01% 4062
2025
Q2 		$3.74M Hold
13,000
– – ﹤0.01% 3417
2025
Q1 		$4.01M Buy
13,000
+11,000
+550% +$3.77M ﹤0.01% 3349
2024
Q4 		$706K Buy
+2,000
New +$735K ﹤0.01% 4854
2024
Q3 		– Sell
-20,000
Closed -$6.37M – 7696
2024
Q2 		$6.37M Hold
20,000
– – ﹤0.01% 2843
2024
Q1 		$4.59M Buy
+20,000
New +$4.51M ﹤0.01% 3175
2023
Q2 		– Sell
-19,200
Closed -$4.3M – 7355
2023
Q1 		$4.3M Buy
+19,200
New +$4.73M ﹤0.01% 2952
2019
Q2 		– Sell
-131,100
Closed -$15.4M – 6028
2019
Q1 		$15.4M Buy
+131,100
New +$15.3M ﹤0.01% 1730

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

JP Morgan Chase's UTHR Position: Q1 2026 in Review

JP Morgan Chase increased its United Therapeutics (UTHR) stake by 11% in Q1 2026, buying an estimated $14.6M and bringing the position to 291,621 shares worth $172M. The position accounts for 0.01% of the portfolio, ranked #759.

JP Morgan Chase first reported a position in UTHR in Q2 2013 and has held it in 52 quarters since. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • JP Morgan Chase held 291,621 shares of United Therapeutics worth $172M as of Q1 2026.
  • JP Morgan Chase bought 29,406 United Therapeutics shares in Q1 2026, an estimated $14.6M.
  • United Therapeutics made up 0.01% of JP Morgan Chase's portfolio in Q1 2026, its #759 holding.
  • JP Morgan Chase first reported a position in United Therapeutics in Q2 2013 and has held it in 52 quarters since.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.